Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Bristol-Myers Squibb Company(BMY) | 0 | 295,000 | +295,000 | $0 | $17.99M | 7.83% | +$17.99M |
| Amgen Inc.(AMGN) | 38,090 | 50,000 | +11,910 | $9.93M | $15.58M | 6.78% | +$5.65M |
| Biogen Inc.(BIIB) | 0 | 113,500 | +113,500 | $0 | $15.53M | 6.76% | +$15.53M |
| Eli Lilly and Company(LLY) | 0 | 18,000 | +18,000 | $0 | $14.87M | 6.47% | +$14.87M |
| Insmed Incorporated(INSM) | 210,884 | 186,384 | -24,500 | $14.56M | $14.22M | 6.19% | -$340.2K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 406,803 | 379,303 | -27,500 | $17.11M | $13.73M | 5.98% | -$3.38M |
| BridgeBio Pharma, Inc.(BBIO) | 560,344 | 390,644 | -169,700 | $15.38M | $13.50M | 5.88% | -$1.87M |
| Perrigo Company plcSHS(PRGO) | 294,517 | 479,517 | +185,000 | $7.57M | $13.45M | 5.85% | +$5.87M |
| Roivant Sciences Ltd.SHS(ROIV) | 0 | 1,300,000 | +1,300,000 | $0 | $13.12M | 5.71% | +$13.12M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 584,883 | 801,806 | +216,923 | $12.89M | $12.32M | 5.37% | -$567.1K |
| Royalty Pharma plcCL A(RPRX) | 764,859 | 356,894 | -407,965 | $19.51M | $11.11M | 4.84% | -$8.40M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 112,500 | 205,000 | +92,500 | $6.23M | $10.53M | 4.59% | +$4.30M |
| Verona Pharma PlcADS | 0 | 160,000 | +160,000 | $0 | $10.16M | 4.42% | +$10.16M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 0 | 24,000 | +24,000 | $0 | $7.95M | 3.46% | +$7.95M |
| Summit Therapeutics Inc.(SMMT) | 0 | 400,000 | +400,000 | $0 | $7.72M | 3.36% | +$7.72M |
| Halozyme Therapeutics, Inc.(HALO) | 0 | 120,000 | +120,000 | $0 | $7.66M | 3.33% | +$7.66M |
| Cytokinetics, Incorporated(CYTK) | 0 | 175,000 | +175,000 | $0 | $7.03M | 3.06% | +$7.03M |
| Agios Pharmaceuticals, Inc.(AGIO) | 301,623 | 235,350 | -66,273 | $9.91M | $6.90M | 3.00% | -$3.02M |
| Centessa Pharmaceuticals PlcADS | 147,076 | 418,127 | +271,051 | $2.46M | $6.01M | 2.62% | +$3.55M |
| Arcus Biosciences, Inc.(RCUS) | 0 | 731,818 | +731,818 | $0 | $5.74M | 2.50% | +$5.74M |
| Newamsterdam Pharma Company ORDINARY SHARES | 337,152 | 221,152 | -116,000 | $8.66M | $4.53M | 1.97% | -$4.14M |
| AbbVie Inc.(ABBV) | 101,996 | 0 | -101,996 | $18.12M | $0 | — | -$18.12M |
| Akero Therapeutics Inc | 230,000 | 0 | -230,000 | $6.40M | $0 | — | -$6.40M |
| Janux Therapeutics, Inc.(JANX) | 120,000 | 0 | -120,000 | $6.42M | $0 | — | -$6.42M |
| Johnson & Johnson(JNJ) | 141,572 | 0 | -141,572 | $20.47M | $0 | — | -$20.47M |
| Moderna, Inc.(MRNA) | 197,500 | 0 | -197,500 | $8.21M | $0 | — | -$8.21M |
| Neumora Therapeutics, Inc.(NMRA) | 150,000 | 0 | -150,000 | $1.59M | $0 | — | -$1.59M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 31,500 | 0 | -31,500 | $22.44M | $0 | — | -$22.44M |
| Sarepta Therapeutics, Inc.(SRPT) | 124,256 | 0 | -124,256 | $15.11M | $0 | — | -$15.11M |
| Vera Therapeutics, Inc.CL A(VERA) | 212,696 | 0 | -212,696 | $8.99M | $0 | — | -$8.99M |
| Viridian Therapeutics, Inc.(VRDN) | 628,677 | 0 | -628,677 | $12.05M | $0 | — | -$12.05M |